Cara Therapeutics, Inc. / Estimates

    Fiscal Year Revenue Net income Net margin Free cash flow FCF margin
    (estimated) €0.00 +NaN% -€93.24M +51.9% N/A N/A N/A
    (estimated) €0.00 +NaN% -€61.36M +56.4% N/A N/A N/A
    (estimated) €0.00 -100.0% -€39.24M +76.7% N/A N/A N/A
    (estimated) €315.59K -94.8% -€22.21M -63.3% -7,037.8% -60 pp N/A N/A
    €6.09M -66.0% -€60.45M -40.2% -993.0% -4.3 pp -€51.07M -33.3% -838.9% -4.1 pp
    €17.88M -49.9% -€101.09M +42.1% -565.2% -3.7 pp -€76.51M +14.0% -427.8% -2.4 pp
    €35.71M +81.8% -€71.15M -5.4% -199.2% +1.8 pp -€67.12M +31.0% -187.9% +0.73 pp
    €19.64M -83.0% -€75.22M -1,148.7% -383.0% -3.9 pp -€51.22M +1,068.7% -260.8% -2.6 pp
    €115.22M +579.3% €7.17M -107.9% 6.2% +5.4 pp -€4.38M -95.3% -3.8% +5.5 pp
    €16.96M +47.6% -€90.73M +43.7% -534.9% +0.15 pp -€93.15M +391.3% -549.2% -3.8 pp
    €11.49M +1,378.5% -€63.13M +27.3% -549.5% +58 pp -€18.96M -59.4% -165.0% +58 pp
    €777.04K +959.3% -€49.58M +1.5% -6,380.4% +600 pp -€46.72M +17.4% -6,012.0% +480 pp
    €73.35K -97.7% -€48.86M +132.0% -66,604.7% -660 pp -€39.80M +117.5% -54,260.5% -540 pp
    €3.24M +19.7% -€21.06M +39.1% -649.2% -0.91 pp -€18.30M +21.9% -564.2% -0.10 pp
    €2.71M -73.4% -€15.14M +347.8% -558.5% -5.3 pp -€15.01M -721.0% -554.0% -5.8 pp
    €10.20M +905.4% -€3.38M -36.8% -33.1% +4.9 pp €2.42M -147.0% 23.7% +5.3 pp
    €1.02M +∞% -€5.35M -36.0% -527.0% -5.3 pp -€5.14M -11.7% -506.8% -5.1 pp
    €0.00 -€8.36M N/A -€5.83M N/A

    Notifications